{{t.titulosHerramientas.nube}}

{{t.titulosHerramientas.numeros}}

Model of teleconsultation pharmaceutical integrated in the electronic clinical history of the patient

Abstract: Objective: Describe the phases of implementation, scaling and integration of a pharmacy teleconsultation model in electronic history, to coordinate the care transition of patients. Method: Descriptive and retrospective study in a health area of 500,000 inhabi

en es

{{t.titulosSecciones.herramientas}}
{{t.titulosSecciones.compartir}}
Negative pressure therapy with instillation for the treatment of infected wounds: recommendations of utilization based on evidence

Abstract: Objective: To establish recommendations related to negative pressure therapy with instillation according to effectiveness, safety, efficiency, consensus guidelines and stability data of instillation solutions. Method: A literature search was conducted to comp

en es

{{t.titulosSecciones.herramientas}}
{{t.titulosSecciones.compartir}}
Clinical-economic impact of the change of protocol for use of basiliximab in liver transplant

Abstract: Objective: Evaluation of the clinical and economic impact after the protocol change of basiliximab use in orthohepatic transplant. Method: Retrospective study in which all liver transplant patients were included during the years 2013, 2014 and until February

en es

{{t.titulosSecciones.herramientas}}
{{t.titulosSecciones.compartir}}
Medicines under additional monitoring in the European Union

Abstract: Objective: The objective of this study was to analyse the characteristics of medicines subject to additional monitoring. We assessed the following aspects: the criteria applied to approve a medicine as being subject to additional monitoring; the authorized di

en es

{{t.titulosSecciones.herramientas}}
{{t.titulosSecciones.compartir}}
Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients

Abstract: Objective: To calculate the persistence, over a period of eight years, the retention rate of first and second-line of treatment with biological agents in patients with rheumatoid arthritis, spondyloarthritis and psoriatic arthritis and to compare retention ra

en es

{{t.titulosSecciones.herramientas}}
{{t.titulosSecciones.compartir}}
Concordance between pharmacotherapeutic complexity calculated and perceived by HIV+ patients with antiretroviral treatment

Abstract: Objective: To determine the difference between the pharmacotherapeutic complexity index by Medication Regimen Complexity Index and it’s perceived by patients through a visual analogue scale in patients HIV+ with antiretroviral treatment. Method: Prospective,

en es

{{t.titulosSecciones.herramientas}}
{{t.titulosSecciones.compartir}}

Criterios de Evaluación
Criterios Básicos de Admisión Criterios Básicos de Admisión
{{criterio.prioridadCriterio}}. {{criterio.observaciones}}
{{criterio.prioridadCriterio}}. {{criterio.observaciones}}
Criterios Altamente Valorados / Criterios Deseables Criterios Cualitativos
{{criterio.prioridadCriterio}}. {{criterio.observaciones}}
{{criterio.prioridadCriterio}}. {{criterio.observaciones}}
Criterios Altamente Valorados Cuantitativos
{{criterio.prioridadCriterio}}. {{criterio.observaciones}}